Xuebijing injection versus placebo for critically ill patients with severe community-acquired pneumonia:a randomized controlled trial: research results and clinical value / 中华危重病急救医学
Chinese Critical Care Medicine
;
(12): 1327-1331, 2019.
Article
in Chinese
| WPRIM
| ID: wpr-791075
ABSTRACT
This article is based on the research paper named Xuebijing injection versus placebo for critically ill patients with severe community-acquired pneumonia a randomized controlled trial which was published in Critical Care Medicine (CCM), introducing its study results and relevant clinical value. Moreover, we attached two peer experts' comments on this study for the readers' reference.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
Language:
Chinese
Journal:
Chinese Critical Care Medicine
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS